INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 29 February 2012
|
Total net assets |
£114.7m |
|
NAV per share |
206.8p |
|
Share price |
183.0p |
|
Total value of unquoted investments |
£18.2m |
|
Total number of portfolio companies |
67 |
|
Cash |
8% NAV |
|
Cash committed and reserved to unquoted investments |
(8)% NAV |
|
Portfolio companies with < 1 year of cash |
9.4% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
4.4 |
|
Celgene |
4.2 |
|
Teva |
4.0 |
|
Insulet |
3.8 |
|
Alexion |
3.5 |
|
Pharmaxis Biogen Shire |
3.4 3.1 2.8 |
|
Gilead Aptiv Solutions |
2.8 2.8 |
|
|
----------- |
|
Total |
34.8 |
|
Geographical Allocation |
% |
|
United States & Canada |
70 |
|
Europe |
15 |
|
Israel |
4 |
|
Australia |
3 |
|
Cash |
8 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
76 |
|
Unquoted |
16 |
|
Cash |
8 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 MARCH 2012